Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To determine whether progesterone receptor (PgR) status provides additional value
to estrogen receptor (ER) status and improves prediction of benefit from endocrine
treatment among patients with primary breast cancer.